Kevin Barr Selected Research

Oculodentodigital Dysplasia

1/2022	Interrogation of Carboxy-Terminus Localized GJA1 Variants Associated with Erythrokeratodermia Variabilis et Progressiva.
12/2020	Effects of Reduced Connexin43 Function on Mandibular Morphology and Osteogenesis in Mutant Mouse Models of Oculodentodigital Dysplasia.
1/2020	Effects of reduced connexin43 function on skull development in the Cx43I130T/+ mutant mouse that models oculodentodigital dysplasia.
2/2014	Myogenic bladder defects in mouse models of human oculodentodigital dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin Barr Research Topics

Disease

4	Oculodentodigital Dysplasia 01/2022 - 02/2014
2	Deafness (Deaf Mutism) 11/2020 - 01/2017
2	Abscess 11/2015 - 12/2014
2	Infections 11/2015 - 12/2014
1	Erythrokeratodermia Variabilis 01/2022
1	Ototoxicity 11/2020
1	Neoplasms (Cancer) 03/2019
1	Melanoma (Melanoma, Malignant) 03/2019
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Ichthyosis (Xeroderma) 01/2017
1	Skin Diseases (Skin Disease) 01/2017
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 01/2017
1	Keratitis 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Hearing Loss (Hearing Impairment) 12/2016
1	Joint Diseases (Joint Disease) 08/2015
1	Osteoarthritis 08/2015

Drug/Important Bio-Agent (IBA)

5	Connexin 43 (Connexin43)IBA 01/2022 - 02/2014
3	disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA 12/2020 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2016
2	Interleukin-17 (Interleukin 17)IBA 11/2015 - 12/2014
2	Interleukin-22 (IL-22)IBA 11/2015 - 12/2014
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Phosphotransferases (Kinase)IBA 03/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2019
1	CateninsIBA 03/2019
1	Keratin-6 (Keratin 6A)IBA 01/2017
1	Keratin-14 (Keratin 14)IBA 01/2017
1	Filaggrin ProteinsIBA 01/2017
1	ConnexinsIBA 01/2017
1	Neutralizing AntibodiesIBA 11/2015
1	Interferon-gamma (Interferon, gamma)IBA 11/2015
1	Glycoproteins (Glycoprotein)IBA 12/2014
1	Antimicrobial Cationic PeptidesIBA 12/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014
1	AntigensIBA 12/2014
1	VaccinesIBA 12/2014

Therapy/Procedure

1	Investigational Therapies (Experimental Therapy) 03/2019
1	Therapeutics 08/2015